Kyowa Kirin (OTCMKTS:KYKOF) Shares Up 14.6% – Here’s What Happened

Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF)’s stock price was up 14.6% during trading on Tuesday . The stock traded as high as $18.00 and last traded at $18.00. Approximately 800 shares traded hands during trading, a decline of 78% from the average daily volume of 3,650 shares. The stock had previously closed at $15.71.

Wall Street Analysts Forecast Growth

Separately, The Goldman Sachs Group cut shares of Kyowa Kirin to a “sell” rating in a research report on Tuesday, December 16th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has an average rating of “Sell”.

Kyowa Kirin Stock Up 14.6%

The business has a 50 day moving average price of $15.79 and a two-hundred day moving average price of $16.21.

About Kyowa Kirin

Kyowa Kirin Co, Ltd. is a global biopharmaceutical company headquartered in Tokyo, Japan, specializing in the research, development and commercialization of innovative therapies. Established through the merger of Kyowa Hakko Kogyo Co, Ltd. and Kirin Pharma Co, Ltd. in 2008, the company operates as part of the Kirin Group and pursues a mission of delivering cutting-edge medicines in areas of high unmet medical need. Its corporate structure supports integrated research and development, manufacturing and worldwide licensing activities.

The company’s therapeutic focus spans oncology, nephrology, immunology and central nervous system disorders.